Mayne Pharma Group Ltd.ASX: MYX

Mayne Pharma enters Scheme Implementation Deed with Cosette

· Issued by Mayne Pharma Group Ltd.

Filed with ASX · · 120 pages · English

Summary by 6ix AI

Mayne Pharma Group Ltd. has entered into a Scheme Implementation Deed with Cosette Pharmaceuticals, Inc. for the acquisition of Mayne Pharma at a specified cash price per share, which represents a significant premium to its recent share price. The Mayne Pharma Board unanimously recommends that shareholders vote in favor of the Scheme, pending an independent expert's conclusion that it is in their best interests. The transaction is fully funded and subject to customary conditions, including regulatory approvals and shareholder consent.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Mayne Pharma Group Ltd. on 6ix

Earlier from Mayne Pharma

Later from Mayne Pharma

All Mayne Pharma news releases